BLADDER UROTHELIAL CARCINOMA
Clinical trials for BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Targeted drug combo tested to fight tough bladder cancer
Disease control TerminatedThis study aimed to see if a targeted pill (erdafitinib) alone or combined with an immunotherapy drug (atezolizumab) could shrink aggressive bladder tumors before surgery. It was for patients whose cancer had grown into the muscle wall of the bladder and who could not receive the…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New hope for bladder preservation in advanced cancer
Disease control OngoingThis study is testing whether adding a drug called durvalumab (an immunotherapy) to standard chemotherapy and radiation works better for treating bladder cancer that has spread to nearby lymph nodes. The main goal is to see if the combination helps more patients achieve a complet…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Major trial aims to boost bladder cancer survival with new drug combo
Disease control OngoingThis large, late-stage trial is testing whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy and radiation treatment works better for patients with muscle-invasive bladder cancer. The main goal is to see if the combination helps patients live longer while …
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC